“We are entering a golden age of biotech - an age of exponential innovation driven by our increased understanding of biology and accelerating computational technology. We are committed to using our expertise to accelerate our clients' advances in human health, nutrition, therapeutics, diagnostics and behavior, creating profound advances for humanity.”
Born out of the venture capital world, we were created by investors to accelerate high growth companies.
Analyze proteomics data to determine the MOA of a novel drug candidate that showed promise in in-vitro and in-vivo studies
A better way to diagnose patients with depression and anxiety for a company bringing new therapeutics to market for neurobehavioral disorders
Analyze plant genomic data and recommend genetic engineering targets to increase yield and resilience of important, staple food crops using a scalable AI platform.
Our take on the world of life sciences, data science, and technologySee all Blogs
Our team has 100+ publications in genomics, neuroscience, multi-omic pathway analysis, oncology, and physics. We understand the domain and are able to move faster to solve hard problems.
We integrate product management, software engineering and data science to deliver scalable, automated solutions.
Tools and infrastructure for AI applications are changing rapidly. We bring technology from the tech industry to the life sciences industry.
We recruit people who want to have a real, beneficial impact on people’s lives and make the world a better place.
Mercury Data Science was created to enable high growth VC ecosystem companies to move faster. We know that technical problem solving must be aligned with business strategy.
We succeed when our clients succeed. We are willing to take risks alongside our clients.